Breaks Categories: News

WednesdayJan 17, 2024 3:04 pm

NetworkNewsBreaks – Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) (FSE: CWY0) Selects Aegis Capital Corp. as Sole Bookrunner for $2.4M Private Placement

Clearmind Medicine (NASDAQ: CMND) (CSE: CMND) (FSE: CWY0), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, has chosen Aegis Capital Corp. to act as sole bookrunner on its registered direct and private placement. According to the announcement, the placement is valued at $2.4 million. In the wealth management and investment banking business since 1984, Aegis is focused on providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. To view the full press release, visit https://nnw.fm/8uZrT About Clearmind…

Continue Reading

WednesdayJan 17, 2024 2:38 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Present at 26th Annual Needham Growth Conference

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will be participating in this month’s Needham Growth Conference. D-Wave, which is the world’s first commercial supplier of quantum computers, will be represented at the conference by CEO Alan Baratz and CFO John Markovich, who are slated to present at 3 p.m. ET on Jan. 19, 2024. A recording of the presentation will be available on the company’s website following the presentation. In addition, members of the D-Wave management team will be available for one-on-one meetings with investors. To view the presentation, visit https://nnw.fm/JMTCi To view…

Continue Reading

WednesdayJan 17, 2024 2:07 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on 2023 Financial Results, Provides Business Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a report on its financial results for the 12-month period ended Sept. 30, 2023; the company also reported on its current business operations. In the report, the company noted key achievements throughout the year, including the company recording its first revenues of $366,000 and delivering vehicles valued at $652,200 to Randy Marion Automotive for resale in September; the production of Class 3 (the Mullen THREE) vehicles beginning in August 2023 and production Class 1 (the Mullen ONE) beginning in November 2023; and by year-end delivering 100 Class 1…

Continue Reading

WednesdayJan 17, 2024 1:54 pm

NetworkNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Announced Seasoned Veteran as New CTO

HUB Cyber Security (NASDAQ: HUBC), a developer of confidential computing cybersecurity solutions and services, has named a new chief technology officer. According to the announcement, the strategic appointment of Nachman Geva as CTO “is meticulously crafted to position HUB Security at the forefront of the cybersecurity for the data fabric market, leveraging Geva's proven high-tech data analytics expertise and stellar track record.” Geva has more than 20 years of leadership experience in high-tech data analytics, including guiding key teams, launching successful software products, and excelling in big data applications, analytics, search, data warehousing, IoT and data integration. The company’s management…

Continue Reading

WednesdayJan 17, 2024 9:54 am

NetworkNewsBreaks – GEMXX Corporation (GEMZ) Announces Participation at Sequire Investor Summit in Puerto Rico

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, will be presenting at this month’s Sequire Investor Summit 2024. Sequire Investor Summit: Puerto Rico is slated for Jan. 23–25, 2024, in San Juan. According to the announcement, the three-day event is designed to provide an array of exciting opportunities for funds, companies and investors. The event agenda features more than 40 presentations from leading public companies as well as panel discussions and interactive sessions focused on addressing the latest trends and innovations in investor relations and technology. Puerto Rico was chosen as the site because it is home…

Continue Reading

TuesdayJan 16, 2024 4:03 pm

NetworkNewsBreaks – Upstream to Shine the Spotlight on the Future of Market Dynamics in Microcap Conference 2024

A recent blog written by Fernanda De La Torre highlights that Upstream will be sponsoring and meeting with issuers at The Microcap Conference. The event is slated to take place Jan. 30 through Feb. 1, 2024, in Atlantic City, New Jersey. The piece reads, “Members of the Upstream team will be in attendance to answer questions on why issuers should dual list on Upstream. We’ll have a dedicated booth where you can discover the opportunities of reaching a global audience through dual listing on Upstream’s next-generation market and trading app. We’re looking forward to connecting with U.S. and international issuers…

Continue Reading

TuesdayJan 16, 2024 3:47 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Ready to Challenge’ with New Five RS SUV, Reports ‘Road Track’ Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its Mullen Five RS were spotlighted in a recent “Road Track” article. The article noted that the sporty new model, which was revealed at CES 2024, is “ready to challenge Tesla and Lucid in the performance EV space. . . . Known as the Mullen Five RS, this electric crossover promises to bring over 1000 hp and a sub-2.0-second 0-60 mph sprint.” The article provided a background look at Mullen, which was incorporated in 2014 and comprises pieces of Coda Motor Cars and Mullen Motors. Calling the Five RS…

Continue Reading

TuesdayJan 16, 2024 3:35 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces New Project Win with Well-Known Tracking-Solutions Partner

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has been awarded a new project with a well-known Canadian industry partner in the tracking-solutions sector. SuperCom announced the new project, noting that it marks another milestone in the company’s journey, “building on the company’s successful history of delivering top-tier services and technologies.” Revenue generation from the new contract is anticipated to start in Q1 2024. According to the announcement, the new project “represents a new chapter in SuperCom’s long-standing collaboration with this partner, transitioning from successful collaboration for providing RF-based tracking…

Continue Reading

TuesdayJan 16, 2024 3:27 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Provides Update on Litigation

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today provided an update regarding its litigation with GBB Drink Lab Inc. (“GBB”). In May 2023, GBB filed a lawsuit against FSD Pharma alleging a material breach of a mutual nondisclosure agreement and trade secret misappropriation. FSD Pharma has categorically denied these allegations and filed a motion to dismiss the lawsuit. On Jan. 8, 2024, the court denied the motion to dismiss, which means only that FSD Pharma will now proceed with discovery. The company is confident that…

Continue Reading

TuesdayJan 16, 2024 3:14 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies. In a recent human pilot study with seven volunteers, Lexaria demonstrated superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The positive results were sufficient to encourage a much more thorough and expanded investigation. The objective of the new planned studies, as detailed in the announcement, is…

Continue Reading